Literature DB >> 22313957

Glomerular MYH9 expression is reduced by HIV-1.

Thomas Hays1, Vivette D D'Agati, Jonathan A Garellek, Tjani Warren, Marc E Trubin, Deborah P Hyink, John Cijiang He, Paul E Klotman.   

Abstract

BACKGROUND: The continuing disease burden of HIV-associated nephropathy (HIVAN) warrants better elucidation of its pathogenic mechanisms. Given that loss of MYH9 function causes a Mendelian renal disease, we hypothesized that renal expression of MYH9 is down-regulated by HIV-1 in HIVAN pathogenesis. METHOD AND
RESULTS: Using immunofluorescence, we determined that glomerular expression of MYH9 was reduced in the kidneys of HIV-1 transgenic mice. We further determined that Myh9 expression was reduced in HIV-1 transgenic podocytes, statistically significantly at the protein level, and that MYH9 expression was significantly reduced at protein and message level in human podocytes transduced with HIV-1. In analyzing expression in human tissue, we confirmed that MYH9 is abundantly expressed in glomeruli, and podocytes specifically. Finally, we found that MYH9 expression was significantly reduced in human glomeruli in the setting of HIVAN.
CONCLUSION: We conclude that the podocyte host response to HIV-1 includes down-regulation of MYH9 expression, and hypothesize that this down-regulation might play a role in the pathogenesis of HIVAN.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22313957      PMCID: PMC3913730          DOI: 10.1097/QAD.0b013e328351f6cf

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  25 in total

Review 1.  The acute, the chronic and the news of HIV-related renal disease in Africa.

Authors:  Craig G Arendse; Nicola Wearne; Ikechi G Okpechi; Charles R Swanepoel
Journal:  Kidney Int       Date:  2010-06-09       Impact factor: 10.612

2.  Association of trypanolytic ApoL1 variants with kidney disease in African Americans.

Authors:  Giulio Genovese; David J Friedman; Michael D Ross; Laurence Lecordier; Pierrick Uzureau; Barry I Freedman; Donald W Bowden; Carl D Langefeld; Taras K Oleksyk; Andrea L Uscinski Knob; Andrea J Bernhardy; Pamela J Hicks; George W Nelson; Benoit Vanhollebeke; Cheryl A Winkler; Jeffrey B Kopp; Etienne Pays; Martin R Pollak
Journal:  Science       Date:  2010-07-15       Impact factor: 47.728

3.  Patients with Epstein-Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease.

Authors:  Takashi Sekine; Mutsuko Konno; Satoshi Sasaki; Suzuko Moritani; Takuma Miura; Wai-shan Wong; Hisanori Nishio; Toshihiro Nishiguchi; Miyako Yoshinari Ohuchi; Shigeru Tsuchiya; Takeshi Matsuyama; Hirokazu Kanegane; Komei Ida; Kenichiro Miura; Yutaka Harita; Motoshi Hattori; Shigeru Horita; Takashi Igarashi; Hidehiko Saito; Shinji Kunishima
Journal:  Kidney Int       Date:  2010-03-03       Impact factor: 10.612

4.  The MYH9/APOL1 region and chronic kidney disease in European-Americans.

Authors:  Conall M O'Seaghdha; Rulan S Parekh; Shih-Jen Hwang; Man Li; Anna Köttgen; Josef Coresh; Qiong Yang; Caroline S Fox; W H Linda Kao
Journal:  Hum Mol Genet       Date:  2011-03-23       Impact factor: 6.150

5.  Podocyte-specific deletion of Myh9 encoding nonmuscle myosin heavy chain 2A predisposes mice to glomerulopathy.

Authors:  Duncan B Johnstone; Jidong Zhang; Britta George; Catherine Léon; Christian Gachet; Hetty Wong; Rulan Parekh; Lawrence B Holzman
Journal:  Mol Cell Biol       Date:  2011-03-14       Impact factor: 4.272

6.  MYH9 genetic variants associated with glomerular disease: what is the role for genetic testing?

Authors:  Jeffrey B Kopp; Cheryl A Winkler; George W Nelson
Journal:  Semin Nephrol       Date:  2010-07       Impact factor: 5.299

7.  In vitro expression and characterization of MYH9 mutant alleles linked to hereditary hearing loss.

Authors:  Calvin C Wei; Anil K Lalwani; Anand N Mhatre
Journal:  Otolaryngol Head Neck Surg       Date:  2010-03-25       Impact factor: 3.497

8.  Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15.

Authors:  George W Nelson; Barry I Freedman; Donald W Bowden; Carl D Langefeld; Ping An; Pamela J Hicks; Meredith A Bostrom; Randall C Johnson; Jeffrey B Kopp; Cheryl A Winkler
Journal:  Hum Mol Genet       Date:  2010-02-02       Impact factor: 6.150

9.  Genome-wide linkage analysis of serum creatinine in three isolated European populations.

Authors:  Cristian Pattaro; Yurii S Aulchenko; Aaron Isaacs; Veronique Vitart; Caroline Hayward; Christopher S Franklin; Ozren Polasek; Ivana Kolcic; Zrinka Biloglav; Susan Campbell; Nick Hastie; Gordan Lauc; Thomas Meitinger; Ben A Oostra; Ulf Gyllensten; James F Wilson; Irene Pichler; Andrew A Hicks; Harry Campbell; Alan F Wright; Igor Rudan; Cornelia M van Duijn; Peter Riegler; Fabio Marroni; Peter P Pramstaller
Journal:  Kidney Int       Date:  2009-04-22       Impact factor: 10.612

10.  Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium.

Authors:  M Seri; R Cusano; S Gangarossa; G Caridi; D Bordo; C Lo Nigro; G M Ghiggeri; R Ravazzolo; M Savino; M Del Vecchio; M d'Apolito; A Iolascon; L L Zelante; A Savoia; C L Balduini; P Noris; U Magrini; S Belletti; K E Heath; M Babcock; M J Glucksman; E Aliprandis; N Bizzaro; R J Desnick; J A Martignetti
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

View more
  7 in total

1.  Similar Biophysical Abnormalities in Glomeruli and Podocytes from Two Distinct Models.

Authors:  Addie E Embry; Zhenan Liu; Joel M Henderson; F Jefferson Byfield; Liping Liu; Joonho Yoon; Zhenzhen Wu; Katrina Cruz; Sara Moradi; C Barton Gillombardo; Rihanna Z Hussain; Richard Doelger; Olaf Stuve; Audrey N Chang; Paul A Janmey; Leslie A Bruggeman; R Tyler Miller
Journal:  J Am Soc Nephrol       Date:  2018-03-23       Impact factor: 10.121

2.  Progress in pathogenesis of proteinuria.

Authors:  Aihua Zhang; Songming Huang
Journal:  Int J Nephrol       Date:  2012-05-24

3.  MYH9 and APOL1 gene polymorphisms and the risk of CKD in patients with lupus nephritis from an admixture population.

Authors:  Vinícius Sardão Colares; Silvia Maria de Oliveira Titan; Alexandre da Costa Pereira; Patrícia Malafronte; Mari M Cardena; Sidney Santos; Paulo C Santos; Cíntia Fridman; Rui Toledo Barros; Viktória Woronik
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

4.  Coexpression Analysis of Transcriptome on AIDS and Other Human Disease Pathways by Canonical Correlation Analysis.

Authors:  Yahong Chen; Jinjin Yuan; Xianlin Han; Xiaolong Liu; Xiao Han; Hanhui Ye
Journal:  Int J Genomics       Date:  2017-06-14       Impact factor: 2.326

5.  Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.

Authors:  Stewart T Chang; Matthew J Thomas; Pavel Sova; Richard R Green; Robert E Palermo; Michael G Katze
Journal:  mBio       Date:  2013-02-05       Impact factor: 7.867

6.  Proteomics analysis of the non-muscle myosin heavy chain IIa-enriched actin-myosin complex reveals multiple functions within the podocyte.

Authors:  Thomas Hays; Avi Ma'ayan; Neil R Clark; Christopher M Tan; Avelino Teixeira; Angela Teixeira; Jae W Choi; Nora Burdis; Sung Yun Jung; Amol O Bajaj; Bert W O'Malley; John C He; Deborah P Hyink; Paul E Klotman
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

Review 7.  Life without double-headed non-muscle myosin II motor proteins.

Authors:  Venkaiah Betapudi
Journal:  Front Chem       Date:  2014-07-07       Impact factor: 5.221

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.